Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/57491
Full metadata record
DC FieldValueLanguage
dc.creatorLlanos Bernardeau-Serrapt_BR
dc.creatorAgathe Nguyen-huynhpt_BR
dc.creatorLara Sponagelpt_BR
dc.creatorNathalia Sernizon Guimarãespt_BR
dc.creatorRaphael Augusto Teixeira de Aguiarpt_BR
dc.creatorMilena Soriano Marcolinopt_BR
dc.date.accessioned2023-08-04T19:32:45Z-
dc.date.available2023-08-04T19:32:45Z-
dc.date.issued2021-08-12-
dc.citation.volume2pt_BR
dc.citation.issue3pt_BR
dc.citation.spage338pt_BR
dc.citation.epage359pt_BR
dc.identifier.doihttps://doi.org/10.3390/epidemiologia2030026pt_BR
dc.identifier.issn2673-3986pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/57491-
dc.description.resumoBrazil is among the countries which have faced two devastating infection waves of COVID-19 in the past year. Despite the fact the country has one of the world’s leading immu nization programs, Brazil only slowly established a national COVID-19 vaccination strategy and campaign. This case study is based on an integrative review of primary and secondary literature sources. Different search strategies on Medline and Google Scholar were performed for the case presentation, for the management and outcome of the COVID-19 outbreak and for the state of the COVID-19 vaccination program. Official documents from the Brazilian Ministry of Health, the website of the World Health Organization and pharmaceutical companies were also reviewed. Searches were limited to English, French, German, Portuguese and Spanish. This article describes the Brazilian COVID-19 vaccination campaign and the drivers and barriers to its implementation; and evaluates further investigations needed to have a conclusive overview over the constantly evolving situation. Healthcare inequalities, which were widened during the pandemic, a lack of coordination at the federal level, the absence of federal government support for scientific research and the lack of en dorsement and commitment to the mitigation of the COVID-19 pandemic set the country’s COVID-19 vaccination campaign off to a challenging start. However, Brazil had a well-developed primary care system and national vaccination program prior to the pandemic, which are both important facilitators. At the time of writing, six vaccines are currently available in the country, and the program is advancing. The scientific community needs to continue to investigate the country’s vaccination strategy and its implementation to make sure that maximum effort is undertaken for the health of the Brazilian populationpt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE MEDICINA PREVENTIVA SOCIALpt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofEpidemiologia-
dc.rightsAcesso Abertopt_BR
dc.subjectBrazilpt_BR
dc.subjectCOVID-19pt_BR
dc.subjectDisease Managementpt_BR
dc.subjectMass Vaccinationpt_BR
dc.subjectPandemicpt_BR
dc.subject.otherBrazilpt_BR
dc.subject.otherGerenciamento Clínicopt_BR
dc.subject.otherCOVID-19pt_BR
dc.subject.otherVacinação em Massapt_BR
dc.subject.otherPandemiapt_BR
dc.titleThe COVID-19 Vaccination Strategy in Brazil—A Case Studypt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.mdpi.com/2673-3986/2/3/26pt_BR
dc.identifier.orcid0000-0002-5285-1742pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
The COVID-19 Vaccination Strategy in Brazil—A Case Study pdfa.pdf221.85 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.